GLP-3 is a novel experimental triagonist peptide engineered to simultaneously activate three metabolic hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. By engaging these pathways in preclinical research, GLP-3 enables the study of integrated energy balance, nutrient signaling, and metabolic regulation across multiple receptor systems.
Disclaimer: This peptide is for research and educational purposes only. It is not intended for diagnostic or therapeutic use.
Share positive thoughts and feedback from your customer.
Author
Share positive thoughts and feedback from your customer.
Author
Share positive thoughts and feedback from your customer.